Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes

NCT00263432 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-12-09

No results posted yet for this study

Summary

Implantation of fresh human allogenic chondrocytes in human knee cartilage injuries to obtain a repair and prevention of secondary osteoarthritis

Conditions

  • Cartilage Injuries in the Human Knee

Interventions

PROCEDURE

Human allogenic chondrocytes

Implantation of fresh human allogenic chondrocytes in human knee cartilage injuries

Sponsors & Collaborators

  • University Ghent

    collaborator OTHER
  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Karl Fredrik Almqvist, MD, PhD · University Hospital, Ghent

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-01
Primary Completion
2015-07-01
Completion
2015-07-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00263432 on ClinicalTrials.gov